The Immunopathology of Covid-19
DOI:
https://doi.org/10.47611/jsrhs.v12i4.5869Keywords:
#Immunopathology, #Covid-19, #Immune SystemAbstract
SARS-CoV-2 is a virus causing Covid-19, with a genome encoding proteins for replication. The innate immune system responds rapidly, employing pattern recognition receptors (PRRs) detecting viral presence. Mucosal tissues offer initial defense, with interferons inhibiting viral replication. Inflammatory cytokines and chemokines attract immune cells, sometimes resulting in cytokine storm. However, excessive inflammation may worsen disease outcomes. The adaptive immune system, comprising CD4+ T cells, CD8+ T cells, and B cells, organize targeted responses. CD4+ T cells activate immune cells and coordinate responses, while CD8+ T cells eliminate infected cells using cytotoxic molecules. B cells produce antibodies that neutralize the virus. Memory B and T cells provide long-term immunity, aiding rapid response upon reinfection. Recovered individuals often exhibit reduced reinfection risks due to memory immunity. Vaccines, like mRNA-based and viral vector-based types, stimulate similar immune responses, bolstering immunity and reducing severe illness.
Downloads
References or Bibliography
Boechat, J. L., Chora, I., Morais, A., & Delgado, L. (2021). The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives. Pulmonology, 27(5), 423–437. https://doi.org/10.1016/j.pulmoe.2021.03.008
Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002. Chapter 24, The Adaptive Immune System. Available from: https://www.ncbi.nlm.nih.gov/books/NBK21070/
Sette, A., & Crotty, S. (2021). Adaptive immunity to SARS-CoV-2 and COVID-19. Cell, 184(4), 861–880. https://doi.org/10.1016/j.cell.2021.01.007
Felgenhauer, U., Schoen, A., Gad, H. H., Hartmann, R., Schaubmar, A. R., Failing, K., Drosten, C., & Weber, F. (2020). Inhibition of SARS-CoV-2 by type I and type III interferons. The Journal of biological chemistry, 295(41), 13958–13964. https://doi.org/10.1074/jbc.AC120.013788
Adil, M. T., Rahman, R., Whitelaw, D., Jain, V., Al-Taan, O., Rashid, F., Munasinghe, A., & Jambulingam, P. (2021). SARS-CoV-2 and the pandemic of COVID-19. Postgraduate medical journal, 97(1144), 110–116. https://doi.org/10.1136/postgradmedj-2020-138386
Beyerstedt, S., Casaro, E. B., & Rangel, É. B. (2021). COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 40(5), 905–919. https://doi.org/10.1007/s10096-020-04138-6
Anka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2021). Coronavirus disease 2019 (COVID-19): An overview of immunopathology, serological diagnosis and management. Scandinavian journal of immunology, 93(4), e12998. https://doi.org/10.1111/sji.12998
Sanyal S. (2020). How SARS-CoV-2 (COVID-19) spreads within infected hosts - what we know so far. Emerging topics in life sciences, 4(4), 371–378. https://doi.org/10.1042/ETLS20200165
Mousavizadeh, L., & Ghasemi, S. (2021). Genotype and phenotype of COVID-19: Their roles in pathogenesis. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 54(2), 159–163. https://doi.org/10.1016/j.jmii.2020.03.022
Fehr, A. R., & Perlman, S. (2015). Coronaviruses: an overview of their replication and pathogenesis. Methods in molecular biology (Clifton, N.J.), 1282, 1–23. https://doi.org/10.1007/978-1-4939-2438-7_1
Mohamadian, M., Chiti, H., Shoghli, A., Biglari, S., Parsamanesh, N., & Esmaeilzadeh, A. (2021). COVID-19: Virology, biology and novel laboratory diagnosis. The journal of gene medicine, 23(2), e3303. https://doi.org/10.1002/jgm.3303
Merad, M., Blish, C. A., Sallusto, F., & Iwasaki, A. (2022). The immunology and immunopathology of COVID-19. Science (New York, N.Y.), 375(6585), 1122–1127. https://doi.org/10.1126/science.abm8108
Hosseini, A., Hashemi, V., Shomali, N., Asghari, F., Gharibi, T., Akbari, M., Gholizadeh, S., & Jafari, A. (2020). Innate and adaptive immune responses against coronavirus. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapy, 132, 110859. https://doi.org/10.1016/j.biopha.2020.110859
Published
How to Cite
Issue
Section
Copyright (c) 2023 Pranav Konduru; Jothsna Kethar, Dr. Rajagopal Appavu, P.h.D.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
